Combining clinical risk factors with serum bilirubin levels to predict hyperbilirubinemia in newborns

Archives of Pediatrics and Adolescent Medicine

Volumn 159, Issue 2, 2005, Pages 113-119

  Newman, Thomas B ^a,b   Liljestrand, Petra ^a,b   Escobar, Gabriel J ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

^c KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; CASE CONTROL STUDY; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; GESTATIONAL AGE; HUMAN; MAJOR CLINICAL STUDY; NEWBORN JAUNDICE; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; RISK INDEX; UNITED STATES; VALIDATION PROCESS;

BILIRUBIN; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; HUMANS; INFANT, NEWBORN; JAUNDICE, NEONATAL; MALE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 13244289968     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.159.2.113     Document Type: Article

References (36)

1. American Academy of Pediatrics Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn. Pediatrics. 1994;94:558-565.
2. Kernicterus in full-term infants-United States, 1994-1998. MMWR Morb Mortal Wkly Rep. 2001;50:491-494.
3. Maisels MJ, Newman TB. Jaundice in full-term and near-term babies who leave the hospital within 36 hours: the pediatrician's nemesis. Clin Perinatol. 1998;25:295-302.
4. Maisels MJ, Baltz RD, Bhutani VK, et al. Neonatal jaundice and kernicterus. Pediatrics. 2001;108:763-765.
5. Bhutani VK, Johnson L, Sivieri EM. Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns. Pediatrics. 1999;103:6-14.
6. Hanley J, McNeil B. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
7. Maisels MJ, Newman TB. Predicting hyperbilirubinemia in newborns: the importance of timing. Pediatrics. 1999;103:493-495.
8. Stevenson DK, Fanaroff AA, Maisels MJ, et al. Prediction of hyperbilirubinemia in near-term and term infants. Pediatrics. 2001;108:31-39.
9. Awasthi S, Rehman H. Early prediction of neonatal hyperbilirubinemia. Indian J Pediatr. 1998;65:131-139.
10. Agarwal R, Kaushal M, Aggarwal R, Paul V, Deoari A. Early neonatal hyperbilirubinemia using first day serum bilirubin level. Indian Pediatr. 2002;39:724-730.
11. Sarici SU, Yurdakok M, Serdar MA, et al. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility. Pediatrics [serial online], 2002;109:e53. Accessed November 8, 2004.
12. Alpay F, Sarici SU, Okutan V, Erdem G, Ozcan O, Gokcay E. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatr. 1999;88:216-219.
13. Carbonell X, Botet F, Figueras J, Riu-Godo A. Prediction of hyperbilirubinaemia in the healthy term newborn. Acta Paediatr. 2001;90:166-170.
14. Valaes T. Problems with prediction of neonatal hyperbilirubinemia. Pediatrics. 2001;108:175-177.
15. Newman TB, Escobar GJ, Gonzales V, Armstrong MA, Gardner M, Folck B. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics. 1999;104:1198-1203.
16. American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Clinical Practice Guideline; Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297-316.
17. Newman TB, Xiong B, Gonzales VM, Escobar GJ. Prediction and prevention of extreme neonatal hyperbilirubinemia in a mature health maintenance organization. Arch Pediatr Adolesc Med. 2000;154:1140-1147.
18. Wasson J, Sox H, Neff R, Goldman L. Clinical prediction rules: applications and methodologic standards. N Engl J Med. 1985;313:793-799.
19. Newman TB, Liljestrand P, Escobar GJ. Jaundice noted in the first 24 hours after birth in a managed care organization. Arch Pediatr Adolesc Med. 2002;156:1244-1250.
20. Atkinson LR, Escobar GJ, Takayama JI, Newman TB. Phototherapy use in jaundiced newborns in a large managed care organization: do physicians adhere to the guideline? Pediatrics [serial online]. 2003;111:e555. Accessed November 8, 2004.
21. National Center for Health Statistics. International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM). Los Angeles, Calif: Practice Management Information Corp; 1999.
22. Stata Corp. Stata statistical software: Release 7.0. College Station, Tex: Stata Corp; 2000.
23. Rosenfeld J. Umbilical cord bilirubin levels as a predictor of subsequent hyperbilirubinemia. J Fam Pract. 1986;23:556-558.
24. Kaplan M, Hammerman C, Feldman R, Brisk R. Predischarge bilirubin screening in glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics. 2000;105:533-537.
25. Knudsen A. Prediction of the development of neonatal jaundice by increased umbilical cord blood bilirubin. Acta Paediatr Scand. 1989;78:217-221.
26. Chen JY, Ling UP. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility. Zhonghua Yi Xue Za Zhi (Taipei). 1994;53:13-18.
27. Brown LP, Arnold L, Allison D, Klein ME, Jacobsen B. Incidence and pattern of jaundice in healthy breast-fed infants during the first month of life. Nurs Res. 1993;42:106-110.
28. Meberg A, Johansen KB. Screening for neonatal hyperbilirubinaemia and ABO alloimmunization at the time of testing for phenylketonuria and congenital hypothyreosis. Acta Paediatr. 1998;87:1269-1274.
29. Seidman DS, Ergaz Z, Paz I, et al. Predicting the risk of jaundice in full-term healthy newborns: a prospective population-based study. J Perinatol. 1999;19:564-567.
30. Gale R, Seidman DS, Dollberg S, Stevenson DK. Epidemiology of neonatal jaundice in the Jerusalem population. J Pediatr Gastroenterol Nutr. 1990;10:82-86.
31. Maisels MJ, Vain N, Acquavita AM, de Blanco NV, Cohen A, DiGregorio J. The effect of breast-feeding frequency on serum bilirubin levels. Am J Obstet Gynecol. 1994;170:880-883.
32. Phuapradit W, Chaturachinda K, Auntlamai S. Risk factors for neonatal hyperbilirubinemia. J Med Assoc Thai. 1993;76:424-428.
33. Wood B, Culley P, Roginski C, Powell J, Waterhouse J. Factors affecting neonatal jaundice. Arch Dis Child. 1979;54:111-115.
34. Linn S, Schoenbaum SC, Monson RR, Rosner B, Stybblefield PG, Ryan KJ. Epidemiology of neonatal hyperbilirubinemia. Pediatrics. 1985;75:770-774.
35. Osborn LM, Reiff MI, Bolus R. Jaundice in the full-term neonate. Pediatrics. 1984;73:520-525.
36. Hintz SR, Gaylord TD, Oh W, et al. Serum bilirubin levels at 72 hours by selected characteristics in breastfed and formula-fed term infants delivered by cesarean section. Acta Paediatr. 2001;90:776-781.